Skip to main content

Table 2 Analysed mutations in APP TMD and associated AAOs

From: Spectrum of γ-Secretase dysfunction as a unifying predictor of ADAD age at onset across PSEN1, PSEN2 and APP causal genes

 

APP TMD mutation

Mean AAO (range)

# Cases

Classification

1

L705V

63.4 (50.0–72.0)

5

CAA: Pathogenic

2

A713T

61.3 (49.0–76.0)

13/16 (*)

Uncertain significance

3

T714A

53.0 (44.0–69.0)

10/11 (*)

Pathogenic

4

T714I

37.4 (32.0–42.0)

7

Pathogenic

5

V715A

48.7 (42.0–55.0)

6

Pathogenic

6

V715M

49.3 (41.0–60.0)

4

Pathogenic

7

I716F

33.7 (30.0–47.0)

6

Pathogenic

8

I716M

64.0

1

Not classified

9

I716T

36.0

1

Not classified

10

I716V

55.7 (53.0–58.0)

3

Not classified

11

V717F

44.9 (37.0–52.0)

21

Pathogenic

12

V717G

52.5 (40.0–67.0)

17

Pathogenic

13

V717I

53.9 (41.0–62.0)

61

Pathogenic

14

V717L

46.9 (35.0–59.0)

26

Pathogenic

15

T719N

45.5 (45.0–46.0)

2

Pathogenic

16

T719P

43.0

1

Not classified

17

M722K

49.2 (38.0–56.0)

5

Pathogenic

18

L723P

47.0 (45.0–57.0)

3

Pathogenic

19

K724N

53.5 (52.0–55.0)

2

Not classified

  1. This table presents APP Transmembrane Domain (APP TMD) mutations selected for analysis, their associated AAOs, number of cases, and classification. Mutation AAOs were defined according to the Alzforum database and available literature (see Supplementary Table S2). Mutations reported as pathogenic/likely pathogenic are highlighted in bold. (*) Number of carriers included in this study vs total reported cases according to the Alzforum database